(Source: Cloud DX.)
  • Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000
  • The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture
  • The debentures will bear 18 per cent interest per annum
  • Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care
  • Cloud DX Inc. (CDX) opened trading at C$0.155

Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000.

The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture.

The debentures will mature 12 months after they’re issued and shall bear 18 per cent interest per annum. The principal amount of the debenture is convertible into common shares at a conversion price of $0.15 per share any time prior to the maturity date.

Net proceeds will be used for inventory and general working capital purposes.

The offering is expected to occur in one or more tranches, with the first tranche scheduled to close on or about June 24, 2022.

The debentures and any securities issued upon conversion will be subject to a statutory four-month hold period. The offering is subject to TSX Venture Exchange approval.

Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care.

Cloud DX Inc. (CDX) opened trading at C$0.155.

More From The Market Online
Sony Electronics Announces Second-Generation Flagship Alpha 1 II

Sony’s Alpha 1 II: A new professional photography standard?

Sony (NYSE:SONY) announced the launch of its latest flagship state-of-the-art mirrorless full-frame camera, the Alpha 1 II.
AI generated stock image

Buzz on the Bullboards: Stocks to watch in volatile times.

The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace.